ELISA分析装置市場-世界の産業規模、シェア、動向、機会、予測、タイプ別、モード別、用途別、エンドユーザー別、地域別、競合別、2020年～2030年

世界のELISA分析装置市場は、2024年に6億1,085万米ドルと評価され、2030年までには7億5,924万米ドルに達し、CAGR3.65％で成長すると予測されています。

ELISA（Enzyme-Linked Immunosorbent Assay）分析装置は、抗体、抗原、タンパク質、ホルモンなどの生体分子を検出・定量するために使用される必須の診断機器です。これらのシステムは、免疫学、ワクチン開発、薬剤モニタリングなど、さまざまな用途でますます使用されるようになっています。慢性疾患や感染症による世界の負担の増大は、高精度でハイスループットな診断ソリューションへの需要に拍車をかけており、ELISA分析装置は現代のヘルスケア診断における重要なツールとなっています。ヘルスケアシステムが早期発見、モニタリング、標的治療を優先させる中、ELISA技術は診断ラボ、製薬会社、研究機関で広く採用されています。自動化とアッセイ感度の進歩は、ELISA分析装置の有用性と拡張性を高め続け、精密医療と臨床診断における役割の拡大を支えています。

主要な市場促進要因

慢性疾患と感染症の蔓延

主要な市場課題

ELISA分析装置と消耗品の高コスト

主要市場動向

個別化医療と精密医療に対する需要の高まり

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 ELISA分析装置市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（光学フィルターELISAアナライザー、光学格子ELISAアナライザー）
  • モード別（自動ELISA分析装置、半自動分析装置）
  • 用途別（免疫学、ワクチン開発、薬物モニタリング、その他）
  • エンドユーザー別（バイオテクノロジー企業、製薬会社、契約調査機関、診断研究所）
  • 地域別
  • 企業別（2024年）
• 市場マップ

第6章 北米のELISA分析装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のELISA分析装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋のELISA分析装置市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のELISA分析装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのELISA分析装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界のELISA分析装置市場：SWOT分析

第14章 競合情勢

• Thermo Fisher Scientific Inc.
• Abcam Limited
• Bio-Rad Laboratories, Inc.
• Merck KgaA
• F. Hoffmann-La Roche Ltd
• Danaher Corporation
• Trinity Biotech Plc.
• Agilent Technologies, Inc.
• QIAGEN
• PerkinElmer U.S. LLC.

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global ELISA Analyzers Market was valued at USD 610.85 Million in 2024 and is projected to reach USD 759.24 Million by 2030, growing at a CAGR of 3.65%. ELISA (Enzyme-Linked Immunosorbent Assay) analyzers are essential diagnostic instruments used for detecting and quantifying biomolecules, including antibodies, antigens, proteins, and hormones. These systems are increasingly used across a range of applications such as immunology, vaccine development, and drug monitoring. The growing global burden of chronic and infectious diseases is fueling demand for accurate, high-throughput diagnostic solutions, making ELISA analyzers a critical tool in modern healthcare diagnostics. As healthcare systems prioritize early detection, monitoring, and targeted treatments, ELISA technologies are seeing widespread adoption across diagnostic laboratories, pharmaceutical companies, and research organizations. Advances in automation and assay sensitivity continue to enhance the utility and scalability of ELISA analyzers, supporting their expanding role in precision medicine and clinical diagnostics.

Key Market Drivers

Growing Prevalence of Chronic and Infectious Diseases

The increasing incidence of chronic and infectious diseases is a primary force driving the global ELISA Analyzers Market. Noncommunicable diseases (NCDs) were responsible for approximately 43 million deaths in 2021, accounting for 75% of non-pandemic-related mortality. Notably, 18 million of these deaths occurred in individuals under age 70, with 82% concentrated in low- and middle-income countries (LMICs). Chronic conditions such as diabetes, cancer, cardiovascular disorders, and infectious diseases like HIV/AIDS, hepatitis, and emerging viruses-including COVID-19 and Zika-are placing unprecedented pressure on global health systems. ELISA analyzers, valued for their sensitivity, reliability, and high-throughput capabilities, are being increasingly deployed for disease diagnosis, monitoring, and research. Their ability to support early detection and manage complex disease profiles is especially critical in aging populations and resource-constrained regions, where effective diagnostic infrastructure is essential for reducing morbidity and mortality.

Key Market Challenges

High Costs of ELISA Analyzers and Consumables

A major constraint in the ELISA Analyzers Market is the high cost associated with acquiring and operating these systems. Advanced ELISA analyzers, particularly automated variants, can require investments ranging from tens of thousands to hundreds of thousands of dollars, making them inaccessible for many small to medium-sized laboratories, particularly in LMICs. The financial burden extends beyond equipment procurement to recurring costs for consumables such as reagents, kits, and regular maintenance. This ongoing expense poses a significant barrier to adoption, especially in facilities with limited budgets or operating in price-sensitive markets. These cost pressures often delay upgrades to newer systems or prevent adoption altogether, thereby limiting diagnostic capabilities and widening healthcare disparities between developed and developing regions.

Key Market Trends

Rising Demand for Personalized and Precision Medicine

The evolution of healthcare toward personalized and precision medicine is significantly influencing the ELISA Analyzers Market. Precision medicine focuses on tailoring treatment based on individual patient profiles, including genetic, molecular, and environmental factors. ELISA analyzers are playing a pivotal role in this shift due to their ability to detect and quantify disease-specific biomarkers, enabling clinicians to diagnose conditions more accurately and select targeted therapies. These systems are increasingly used in oncology, autoimmune disease management, and genetic testing to guide clinical decision-making. By integrating ELISA technology with genomic and proteomic data, healthcare providers can better predict disease risk and optimize treatment plans. The growing emphasis on early diagnosis, targeted therapies, and treatment monitoring is expected to further accelerate the demand for high-performance ELISA analyzers and advanced assay development.

Key Market Players

• Thermo Fisher Scientific Inc.
• Abcam Limited
• Bio-Rad Laboratories, Inc.
• Merck KgaA
• F. Hoffmann-La Roche Ltd
• Danaher Corporation
• Trinity Biotech Plc.
• Agilent Technologies, Inc.
• QIAGEN
• PerkinElmer U.S. LLC

Report Scope:

In this report, the Global ELISA Analyzers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

ELISA Analyzers Market, By Product:

• Optical Filter ELISA Analyzer
• Optical Grating ELISA Analyzers

ELISA Analyzers Market, By Mode:

• Automated ELISA Analyzers
• Semi-Automated Analyzers

ELISA Analyzers Market, By Application:

• Immunology
• Vaccine Development
• Drug Monitoring
• Others

ELISA Analyzers Market, By End User:

• Biotechnology Companies
• Pharmaceutical Companies
• Contract Research Organization
• Diagnostic Laboratories

ELISA Analyzers Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global ELISA Analyzers Market.

Available Customizations:

Global ELISA Analyzers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. ELISA Analyzers Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Optical Filter ELISA Analyzer, Optical Grating ELISA Analyzers)
  • 5.2.2. By Mode (Automated ELISA Analyzers, Semi-Automated Analyzers)
  • 5.2.3. By Application (Immunology, Vaccine development, Drug Monitoring, Others)
  • 5.2.4. By End user (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organization, Diagnostic Laboratories)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America ELISA Analyzers Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Mode
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States ELISA Analyzers Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Mode
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada ELISA Analyzers Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Mode
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico ELISA Analyzers Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Mode
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe ELISA Analyzers Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Mode
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany ELISA Analyzers Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Mode
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom ELISA Analyzers Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Mode
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy ELISA Analyzers Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Mode
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. France ELISA Analyzers Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Mode
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain ELISA Analyzers Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Mode
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific ELISA Analyzers Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Mode
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China ELISA Analyzers Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Mode
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India ELISA Analyzers Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Mode
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan ELISA Analyzers Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Mode
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea ELISA Analyzers Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Mode
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia ELISA Analyzers Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Mode
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America ELISA Analyzers Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Mode
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil ELISA Analyzers Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Mode
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina ELISA Analyzers Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Mode
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia ELISA Analyzers Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Mode
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa ELISA Analyzers Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Mode
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa ELISA Analyzers Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Mode
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia ELISA Analyzers Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Mode
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE ELISA Analyzers Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Mode
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global ELISA Analyzers Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Abcam Limited
• 14.3. Bio-Rad Laboratories, Inc.
• 14.4. Merck KgaA
• 14.5. F. Hoffmann-La Roche Ltd
• 14.6. Danaher Corporation
• 14.7. Trinity Biotech Plc.
• 14.8. Agilent Technologies, Inc.
• 14.9. QIAGEN
• 14.10.PerkinElmer U.S. LLC.

15. Strategic Recommendations

16. About Us & Disclaimer